Evaluating the Effects of Rivastigmine on Decision-Making in Patients with Mild Cognitive Impairment by Cambridge Neuropsychological Test Automated Battery (CANTAB); A Randomized, Double-Blind, Placebo-Controlled Trial.
Setayesh SadeghiFatemeh MohammadianMehdi Tehrani DoostKheirollah GholamiNiayesh MohebbiPublished in: Iranian journal of pharmaceutical research : IJPR (2023)
According to the results, rivastigmine significantly improved the primary decision-making outcomes in comparison with placebo.